SBSB
OMCL icon

Sullivan, Bruyette, Speros & Blaney’s Omnicell OMCL Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,079
Closed -$130K – 424
2020
Q4 		$130K Buy
+1,079
New +$106K 0.01% 359

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's OMCL Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney sold out of Omnicell (OMCL) in Q1 2021, closing a stake of 1,079 shares — an estimated $130K sold.

Sullivan, Bruyette, Speros & Blaney first reported a position in OMCL in Q4 2020 and held it in 1 quarter. The position peaked at $130K in Q4 2020. 380 funds tracked by Wall St. Rank hold OMCL as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney reported no remaining Omnicell position as of Q1 2021 after selling out during the quarter.
  • Sullivan, Bruyette, Speros & Blaney sold 1,079 Omnicell shares in Q1 2021, an estimated $130K.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Omnicell in Q4 2020 and held it in 1 quarter.
  • Sullivan, Bruyette, Speros & Blaney's Omnicell position peaked at $130K in Q4 2020.
  • 380 funds tracked by Wall St. Rank held Omnicell as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.